2018 annual financial data
Axsome Therapeutics 2018 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -32,846,577 USD and net income was -30,965,464 USD.
Operating cash flow was -30,053,701 USD.
Get free Axsome Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -32,846,577 USD
- Net income
- -30,965,464 USD
- Operating cash flow
- -30,053,701 USD